JGP Global Gestao de Recursos’s Kymera Therapeutics KYMR Stock Holding History

JGP Global Gestao de Recursos’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,991	Closed	-$241K	–	44
2024 Q4	$241K	Sell	5,991 -1	-0%	-$45	0.55%	34
2024 Q3	$284K	Buy	+5,992	New	+$265K	0.55%	31
2024 Q2	–	Sell	-5,183	Closed	-$208K	–	50
2024 Q1	$208K	Buy	+5,183	New	+$185K	0.13%	47

Other funds holding KYMR

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

JGP Global Gestao de Recursos's KYMR Position: Q1 2025 in Review

JGP Global Gestao de Recursos sold out of Kymera Therapeutics (KYMR) in Q1 2025, closing a stake of 5,991 shares — an estimated $241K sold.

JGP Global Gestao de Recursos first reported a position in KYMR in Q1 2024 and held it in 3 quarters. The position peaked at $284K in Q3 2024. 173 funds tracked by Wall St. Rank hold KYMR as of Q1 2025.

JGP Global Gestao de Recursos reported no remaining Kymera Therapeutics position as of Q1 2025 after selling out during the quarter.
JGP Global Gestao de Recursos sold 5,991 Kymera Therapeutics shares in Q1 2025, an estimated $241K.
JGP Global Gestao de Recursos first reported a position in Kymera Therapeutics in Q1 2024 and held it in 3 quarters.
JGP Global Gestao de Recursos's Kymera Therapeutics position peaked at $284K in Q3 2024.
173 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2025.

Based on JGP Global Gestao de Recursos's 13F filing for Q1 2025, filed 9 May 2025.